Dr. Ruoslahti is a founder and the Chairman of the Scientific Advisory Board (SAB) of The Nanotech Company, LLC. He was President and CEO of The Burnham Institute, La Jolla, CA from 1989 to 2002. He remains Distinguished Professor there. Dr. Ruoslahti is a member of the National Academy of Sciences, Institute of Medicine, and the National Academy of Arts and Sciences. He is credited with over 400 scientific papers and is a leading scientist in the extracellular matrix and tumor biology fields. He is the discoverer of the RGD cell adhesion motif and the founder of three biotech companies. Most recently, he has developed a vascular targeting technology and is applying this technology into nanomedicine.